Results 41 to 50 of about 1,211,683 (168)
The direct costs of drug-induced skin reactions
Annals of Agricultural and Environmental Medicine, 2017 Objective The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw.
Nina Kiepurska +4 more
doaj +1 more source
Dr-COVID: Graph Neural Networks for SARS-CoV-2 Drug Repurposing [PDF]
arXiv, 2020 The 2019 novel coronavirus (SARS-CoV-2) pandemic has resulted in more than a million deaths, high morbidities, and economic distress worldwide. There is an urgent need to identify medications that would treat and prevent novel diseases like the 2019 coronavirus disease (COVID-19).
arxiv
What's Good for Washington: Fair Prescription Drug Pricing and the Biotechnology Industry [PDF]
, 2003 The rising cost of prescription drugs is consuming an ever-larger portion of limited funds for basic health care and other important services in Washington state.
Rebecca Kavoussi
core
Hazardous Drinkers and Drug Users in HMO Primary Care: Prevalence, Medical Conditions and Costs [PDF]
, 2006 Summarizes a study of the links between frequent heavy drinking and drug use and medical conditions, the frequency of hazardous drinkers' and drug users' primary care and psychiatry visits, and the resulting costs of their health ...
Deanna Lewis, Jennifer Mertens
core
Promoting adverse drug reaction reporting: comparison of different approaches
Revista de Saúde Pública, 2016 OBJECTIVE To describe different approaches to promote adverse drug reaction reporting among health care professionals, determining their cost-effectiveness.
Inês Ribeiro-Vaz +2 more
doaj +1 more source
Costs of mass drug administration for scabies in Fiji.
PLoS Neglected Tropical Diseases, 2022 In 2019, the Murdoch Children's Research Institute in partnership with the Fiji Ministry of Health and Medical Services carried out an integrated mass drug administration (MDA) for the treatment of scabies and lymphatic filariasis in the Northern ...
Maria Mow +14 more
doaj +1 more source
Drug Discovery Approaches using Quantum Machine Learning [PDF]
arXiv, 2021 Traditional drug discovery pipeline takes several years and cost billions of dollars. Deep generative and predictive models are widely adopted to assist in drug development. Classical machines cannot efficiently produce atypical patterns of quantum computers which might improve the training quality of learning tasks.
arxiv
Medicare Prescription Drug Plans in 2008 and Key Changes Since 2006: Summary of Findings [PDF]
, 2008 Synthesizes findings from prior research on the scope and generosity of drug coverage under Medicare Part D, as well as on changes in drug coverage and costs since 2006.
Elizabeth Hargrave +3 more
core
Drug Supply Chain Optimization for Adaptive Clinical Trials [PDF]
arXiv, 2023 With increasing interest in adaptive clinical trial designs, challenges are present to drug supply chain management which may offset the benefit of adaptive designs. Thus, it is necessary to develop an optimization tool to facilitate the decision making and analysis of drug supply chain planning.
arxiv
Stagnation in the Drug Development Process: Are Patents the Problem? [PDF]
, 2007 The rate of new drug development has stagnated, in spite of large increases in both private and public sector spending on biomedical research. The flip side of slower progress is higher drug costs.
Dean Baker
core